Musculoskeletal toll ‘may start at 20’ in rare disease
Researchers say their study is the first to characterise X-linked hypophosphataemia over the lifespan.
Researchers say their study is the first to characterise X-linked hypophosphataemia over the lifespan.
One in 10, however, express dissatisfaction with pain or function, the Australian registry study shows.
The single-arm trial of the investigational procedureĀ in 40 patients is encouraging, researchers say.
Sydney researchers say their study is the first to compare a mix of treatments.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.